PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.36%
Negative revenue growth while RUN stands at 4.49%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-33.63%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-110.42%
Negative EBIT growth while RUN is at 30.38%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-105.75%
Negative operating income growth while RUN is at 30.38%. Joel Greenblatt would press for urgent turnaround measures.
-111.73%
Negative net income growth while RUN stands at 85.95%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-111.98%
Negative EPS growth while RUN is at 86.36%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-113.46%
Negative diluted EPS growth while RUN is at 86.36%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.55%
Share reduction more than 1.5x RUN's 3.01%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-14.46%
Reduced diluted shares while RUN is at 5.17%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-367.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-441.53%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-61.76%
Negative 10Y revenue/share CAGR while RUN stands at 340.32%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-36.20%
Negative 5Y CAGR while RUN stands at 73.21%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-35.97%
Negative 3Y CAGR while RUN stands at 25.70%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
86.97%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
91.25%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
85.82%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
-1185.23%
Negative 10Y net income/share CAGR while RUN is at 18.85%. Joel Greenblatt sees a major red flag in long-term profit erosion.
54.60%
Positive 5Y CAGR while RUN is negative. John Neff might view this as a strong mid-term relative advantage.
65.83%
Positive short-term CAGR while RUN is negative. John Neff would see a clear advantage in near-term profit trajectory.
-87.55%
Negative equity/share CAGR over 10 years while RUN stands at 641.73%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-78.76%
Negative 5Y equity/share growth while RUN is at 456.69%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-38.27%
Negative 3Y equity/share growth while RUN is at 257.53%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.32%
AR growth is negative/stable vs. RUN's 31.91%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
9.55%
Inventory growth well above RUN's 2.38%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.14%
Negative asset growth while RUN invests at 3.50%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-11.71%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
4.40%
Debt shrinking faster vs. RUN's 9.60%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
53.13%
R&D growth drastically higher vs. RUN's 10.25%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-9.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.